Lipomed Inc - 02142 Cambridge, MA

Business Name: Lipomed Inc
Categorized In:
Address: 1 Broadway # 8, Cambridge, MA 02142
Phone Number: (617) 577-7222
Contact Person: Mario Pasquier, Vice President
Website Address: lipomed.com
NAICS Code: 4242101
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 1997
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $2.500.000 to $4.999.999
Share This Business:
Similar Businesses: Il Pharma Inc - Cambridge, MA 02142
Newco Ls13 - Cambridge, MA 02142
Sanofi Us Services Inc - Cambridge, MA 02142
Shape Pharmaceuticals Inc - Cambridge, MA 02142
Verastem Inc - Cambridge, MA 02142
Targanta Therapeutics Corporation - Cambridge, MA 02142
Edimer Pharmaceuticals - Cambridge, MA 02142
Eleven Biotherapeutics - Cambridge, MA 02142
Constellation Pharmaceuticals - Cambridge, MA 02142
Millennium Pharmaceuticals - Cambridge, MA 02142
Aegerion Pharmaceuticals Inc - Cambridge, MA 02142
Via Cord LLC - Cambridge, MA 02142
Ironwood Pharmaceuticals Inc - Cambridge, MA 02142
Momenta Pharmaceuticals Inc - Cambridge, MA 02142
Alnylam Pharmaceuticals Inc - Cambridge, MA 02142
Sarepta Therapeutics Inc - Cambridge, MA 02142
Zalicus Inc - Cambridge, MA 02142
Clarus Ventures LLC - Cambridge, MA 02142
Gloucester Pharmaceuticals Inc - Cambridge, MA 02142
Akanas Therapeutics Inc - Cambridge, MA 02142

Lipomed Inc provides professional from its single location at the coordinates 42.362035,-71.082517.

The company offers BOTH variables under the SIC code 2834 and NAICS code 4242101, while making an annual revenue of $2.500.000 to $4.999.999 and hiring a total of 1 to 4 employees.

Founded in 1997, the company can now be visited at 1 Broadway # 8, Cambridge, Massachusetts 02142 or contacted through representative Mario Pasquier, Vice President at (617) 577-7222.

For frequently asked questions and further inquiries about professional , get to know more about Lipomed Inc through its company website at lipomed.com. Engage with this business on its social media platforms through on Twitter and on Facebook.